ImmBio - Model MenBioVax - Neisseria Meningitides Novel Vaccine - Brochure
The bacterial pathogen Neisseria meningitidis is a major cause of meningitis. ImmBioVax technology offers a powerful new approach to establish a vaccine with broad, cross-strain protection. ImmBio, supported by Biomedical Catalyst funding, is developing MenBioVax, a single vaccine designed for all Neisseria meningitidis serogroups and ...
